Navigation Links
VetStem Biopharma & Veterinary Growth Partners Join Forces to Increase Member Veterinary Hospital Revenue Through Cutting Edge Medical Offering

San Diego, CA (PRWEB) May 26, 2015

Leading Regenerative Veterinary Medicine® Company VetStem Biopharma, announced the beginning of a long-term relationship with Veterinary Growth Partners, a membership organization that works on behalf of its members to provide access to vital services to veterinary practices.

“I am extremely pleased to count VGP as a dedicated partner in bringing stem cell therapy to more arthritic dog patients nationwide. Concentrating and using stem cells natural abilities to promote damaged tissue healing is a radical change in medical thinking. Changing thought processes is always a slow and difficult endeavor. VGP’s leadership team are experts at helping hospitals evaluate and implement positive change. We are excited they see value in what we do and agreed to work together to help their members learn more about the science and guide them through the implementation of stem cell therapy in their hospitals”, stated Dr Nahama, President and Chief Commercial Officer for VetStem.

“We were convinced to partner with VetStem because of their focus on patient needs and the quality of their services. We see stem cell therapy as a way for our members to differentiate themselves in a quickly changing market. Only veterinarians can offer the service, which is an important competitive factor”, added Robert Sigman, VGP’s President.

VGP members will benefit from a preferential pricing agreement, but will also have access to a full suite of online training and marketing support tools specifically developed with the VGP membership needs in mind.

About VetStem Biopharma.
VetStem Biopharma is a veterinarian lead company that was formed in 2002 to bring regenerative medicine to the profession. This privately held biopharmaceutical enterprise, based near San Diego (California), currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 12 years and 11,000 patients treated by veterinarians for joint, tendon or ligament issues, VetStem has made the regenerative medicine applications a therapeutic reality beyond the realm of research. The VetStem team is focused on developing new clinically practical and affordable veterinary solutions that leverage the natural restorative abilities present in all living creatures. The company’s stated mission being “to extend and enhance the lives of animals by improving the quality of recovery in acute conditions, but also by unlocking ways to slow, stop and ultimately revert the course of chronic diseases”. In addition to its’ own portfolio of patents, Vet-Stem holds exclusive global veterinary licenses to a portfolio of over 55 issued patents in the field of regenerative medicine.

About Veterinary Growth Partners.
Veterinary Growth Partners (VGP) is a membership organization that provides a Pathway to Success for forward-thinking veterinary practice owners and managers. VGP’s consultants and advisors are dedicated to growing members’ profits. They offer a free, proven management system, along with the education, tools, and resources their members need to increase the number of transactions and average transaction charge.

Though VGP focuses on the revenue side of the business first, the company also does its part to help members trim expenses. The VGP team negotiates with industry partners to save money on medicine, equipment, and supplies that veterinary practices use every day. Veterinary Growth Partners works with their members and industry partners to succeed, together.

Kristi Hauta (KHauta(at)Vet-Stem(dot)com)
Marketing Manager
12860 Danielson Court, Suite B
Poway, CA 92064

Robert Sigman (rob(at)vgpvet(dot)com)
President, Veterinary Growth Partners
3930 Bee Cave Rd., Suite 9
Austin, TX 78746

Read the full story at

Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related biology technology :

1. Leading Regenerative Veterinary Medicine Company, VetStem Biopharma, Announces the Addition of Dr Ross Rich as the Director of Clinical Development
2. West Coast Bird Dog Champion Wins US Bird Dog Association Western States National Flushing Champion with the help of Stem Cell Therapy by VetStem.
3. Leading Regenerative Veterinary Medicine Company, VetStem Biopharma announces the addition of Dr Jeffrey Schaffer as the Director of Veterinary Professional Services.
4. VetStem Biopharma -Regenerative Cell Therapy has processed over 11,000 samples
5. Vet-Stem, Inc. Meets New Milestones and Changes Name to VetStem Biopharma
6. Global Biopharmaceutical Contract Manufacturing Market: 10 Year Forecasts
7. Array BioPharma To Present At The Bank Of America Merrill Lynch Healthcare Conference And The UBS Global Healthcare Conference
8. Alise Reicin Joins the Biopharmaceutical Business of Merck KGaA, Darmstadt, Germany as Head of Global Clinical Development
9. PAREXEL Strengthens Commitment To Global Biopharmaceutical Workforce With New PAREXEL Academy Programs
10. PlasmaTech Biopharmaceuticals Appoints Alpha-1 Expert Robert Sandhaus, MD, Ph.D. To Its Scientific Advisory Board
11. PlasmaTech Biopharmaceuticals Provides Strategic Update for 2015 and Review of 2014 Acheivements
Post Your Comments:
(Date:7/31/2020)... , ... July 30, 2020 ... ... cloud-based software for the life sciences industry, today announced the release of ... designed specifically for Medical Science Liaisons (MSLs) and other field medical professionals. ...
(Date:7/18/2020)... ... 16, 2020 , ... “We are thrilled to deliver this new technology to ... of its kind on the market and we were pleased that the IFT jury ... traditional cultured ingredients, creating a natural way to extend the shelf life and improve ...
(Date:7/10/2020)... Va. (PRWEB) , ... July 08, 2020 , ... ... testing services and products, announces a significant expansion of laboratory operations through its ... collection for agencies implementing testing programs. , Bode-CARES provides a ...
(Date:7/10/2020)... ... July 09, 2020 , ... Sentien Biotechnologies, Inc., ... hiring of Allen R. Nissenson, M.D., F.A.C.P., as its Chief Medical Officer. ... Sentien’s lead product, SBI-101. Dr. Nissenson serves as an Emeritus Professor of ...
Breaking Biology Technology:
(Date:8/12/2020)... ... August 12, 2020 , ... Mosio recently announced its ... public health agencies of all sizes. With a focus on tracking symptoms and ... appropriate health care, Mosio helps public health departments automate communications and provide more ...
(Date:7/31/2020)... ... 2020 , ... BioFactura, Inc. today announced a $1 million ... & Technology Office—Chemical and Biological Defense (JSTO-CBD) of the Department of Defense (DoD). ... efficient mammalian cell culture-based bioprocess suitable to meet surge requirement needs for rapid ...
(Date:7/10/2020)... (PRWEB) , ... July 08, 2020 , ... ... on Cell and Gene Therapy Regulation, An FDAnews Webinar, Wednesday, July 22, 2020 ... a comparability study, but what is the most effective way to complete one? ...
Breaking Biology News(10 mins):